Verastem Reports Two-Year RAMP 201 Data in LGSOC
BOSTON — September 28, 2026 Verastem Oncology announced the publication in Gynecologic Oncology of two-year follow-up data from the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
BOSTON — September 28, 2026 Verastem Oncology announced the publication in Gynecologic Oncology of two-year follow-up data from the...
CHESTERBROOK, Pa. — September 24, 2026 Persevere Therapeutics, Inc. announced that the first patient has been enrolled and treated...
BOSTON — September 24, 2026 Verastem Oncology announced that molecular profiling and tumor biomarker findings from the Phase 2...
LAWRENCEVILLE, N.J. — September 22, 2026 IMUNON announced that the Independent Data Monitoring Committee (IDMC) overseeing its Phase 2...
REDWOOD CITY, Calif. — September 18, 2026 Corcept Therapeutics announced that the European Medicines Agency’s Committee for Medicinal Products...
NANJING, China and BASILDON, UK — September 18, 2026 IMPACT Therapeutics and Pharmanovia announced that the Committee for Medicinal...
LAWRENCEVILLE, N.J. — September 10, 2026 IMUNON, Inc. announced a Cooperative Research and Development Agreement (CRADA) with the National...
PRINCETON, N.J., August 31, 2026 PMV Pharmaceuticals announced updated interim data from the Phase 2 pivotal portion of the...
TAIPEI, Taiwan — August 25, 2026 Senhwa Biosciences announced that it has completed patient enrollment in its Phase 1b...
August 24, 2026 | San Jose, California Anixa Biosciences announced that it will present updates on its breast cancer...
